TY - JOUR
T1 - Extracellular matrix-inspired growth factor delivery systems for bone regeneration
AU - Martino, Mikaël M.
AU - Briquez, Priscilla S.
AU - Maruyama, Kenta
AU - Hubbell, Jeffrey A.
N1 - Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Growth factors are very promising molecules to enhance bone regeneration. However, their translation to clinical use has been seriously limited, facing issues related to safety and cost-effectiveness. These problems derive from the vastly supra-physiological doses of growth factor used without optimized delivery systems. Therefore, these issues have motivated the development of new delivery systems allowing better control of the spatiotemporal release and signaling of growth factors. Because the extracellular matrix (ECM) naturally plays a fundamental role in coordinating growth factor activity in vivo, a number of novel delivery systems have been inspired by the growth factor regulatory function of the ECM. After introducing the role of growth factors during the bone regeneration process, this review exposes different issues that growth factor-based therapies have encountered in the clinic and highlights recent delivery approaches based on the natural interaction between growth factor and the ECM.
AB - Growth factors are very promising molecules to enhance bone regeneration. However, their translation to clinical use has been seriously limited, facing issues related to safety and cost-effectiveness. These problems derive from the vastly supra-physiological doses of growth factor used without optimized delivery systems. Therefore, these issues have motivated the development of new delivery systems allowing better control of the spatiotemporal release and signaling of growth factors. Because the extracellular matrix (ECM) naturally plays a fundamental role in coordinating growth factor activity in vivo, a number of novel delivery systems have been inspired by the growth factor regulatory function of the ECM. After introducing the role of growth factors during the bone regeneration process, this review exposes different issues that growth factor-based therapies have encountered in the clinic and highlights recent delivery approaches based on the natural interaction between growth factor and the ECM.
KW - Bone morphogenetic protein
KW - Clinical translation
KW - Controlled delivery
KW - Extracellular matrix
KW - Fibroblast growth factor
KW - Integrins
KW - Platelet-derived growth factor
KW - Vascular endothelial growth factor
UR - http://www.scopus.com/inward/record.url?scp=84947617350&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84947617350&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2015.04.007
DO - 10.1016/j.addr.2015.04.007
M3 - Review article
C2 - 25895621
AN - SCOPUS:84947617350
SN - 0169-409X
VL - 94
SP - 41
EP - 52
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
ER -